MarketPulse
A

$ABBV

64 articles found
43 positive
3 negative
18 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Uterine Fibroid Treatment Market Poised for 7.63% Annual Growth Through 2033

Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.
JNJPFEABBVSYKMDT+9market growthminimally invasive procedures
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Global Lip Augmentation Market Poised to Double by 2035 Amid Rising Demand

Global lip augmentation market expected to double from $7.91B (2025) to $17.37B (2035), driven by social media influence, improved technology, and increased mainstream acceptance.
ABBVGALDYcosmetic proceduresminimally invasive procedures
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

AbbVie Stock Declines Despite Strong Quarterly Results and Pipeline Growth

AbbVie stock fell despite strong Q4 results and 10% revenue growth. Investors worry about Humira patent expiration, though new drugs Skyrizi and Rinvoq show promise.
ABBVearnings reportdividend stock
The Motley FoolThe Motley Fool··Dave Kovaleski

Healthcare Giants Offer Defensive Appeal Amid Market Correction Concerns

Investors anticipate 2026 market volatility, driving interest in defensive healthcare stocks. AbbVie and Merck offer stable dividends and historical resilience during downturns.
MRKABBVdividend stocksdividend yield